BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 27986517)

  • 1. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice.
    Pramyothin P; Manyanont S; Trakarnsanga A; Petsuksiri J; Ithimakin S
    J Hum Nutr Diet; 2016 Dec; 29(6):768-776. PubMed ID: 27028666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
    McClelland S; Andrews JZ; Chaudhry H; Teckie S; Goenka A
    Oral Oncol; 2018 Dec; 87():77-81. PubMed ID: 30527247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy.
    Soria A; Santacruz E; Vega-Piñeiro B; Gión M; Molina J; Villamayor M; Mateo R; Riveiro J; Nattero L; Botella-Carretero JI
    Nutr Hosp; 2017 Jun; 34(3):512-516. PubMed ID: 28627183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators for Enteral Nutrition Use and Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy.
    van der Linden NC; Kok A; Leermakers-Vermeer MJ; de Roos NM; de Bree R; van Cruijsen H; Terhaard CH
    Nutr Clin Pract; 2017 Apr; 32(2):225-232. PubMed ID: 28362572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
    Nugent B; Lewis S; O'Sullivan JM
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007904. PubMed ID: 23440820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
    Nugent B; Lewis S; O'Sullivan JM
    Cochrane Database Syst Rev; 2010 Mar; (3):CD007904. PubMed ID: 20238358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteral feeding in head and neck cancer patients at a UK cancer centre.
    Sheth CH; Sharp S; Walters ER
    J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study.
    Wiggenraad RG; Flierman L; Goossens A; Brand R; Verschuur HP; Croll GA; Moser LE; Vriesendorp R
    Clin Otolaryngol; 2007 Oct; 32(5):384-90. PubMed ID: 17883560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prophylactic percutaneous endoscopic gastrostomy with reactive enteral nutrition in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy: A systematic review.
    Mellors K; Ye X; Van Den Brande J; Wai Ray Mak T; Brown T; Findlay M; Bauer J
    Clin Nutr ESPEN; 2021 Dec; 46():87-98. PubMed ID: 34857252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
    Karsten RT; Stuiver MM; van der Molen L; Navran A; de Boer JP; Hilgers FJM; Klop WMC; Smeele LE
    Oral Oncol; 2019 Jan; 88():172-179. PubMed ID: 30616790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic percutaneous endoscopic gastrostomy in patients with head and neck cancer: Influence on nutritional status, utilisation rate and complications.
    Hausmann J; Kubesch A; Müller von der Grün J; Goettlich CM; Filmann N; Oliver Tal A; Vermehren J; Friedrich-Rust M; Wächtershäuser A; Bojunga J; Blumenstein I
    Int J Clin Pract; 2019 Nov; 73(11):e13405. PubMed ID: 31408231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    Br J Cancer; 2017 Jun; 117(1):15-24. PubMed ID: 28535154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Prophylactic Gastrostomy Tube Placement and Gastrostomy Tube Usage in Patients Treated by Radio(chemo)therapy for Head and Neck Cancer.
    Sieron HL; Eberle F; Gress TM; Mahnken AH; Wiegand S
    Anticancer Res; 2020 Feb; 40(2):1167-1173. PubMed ID: 32014970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma.
    Lee H; Havrila C; Bravo V; Shantz K; Diaz K; Larner J; Read P
    Support Care Cancer; 2008 Mar; 16(3):285-9. PubMed ID: 17680281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tube feeding in patients with head and neck cancer undergoing chemoradiotherapy: A systematic review.
    Bossola M; Antocicco M; Pepe G
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1258-1269. PubMed ID: 35244947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
    Mekhail TM; Adelstein DJ; Rybicki LA; Larto MA; Saxton JP; Lavertu P
    Cancer; 2001 May; 91(9):1785-90. PubMed ID: 11335904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
    Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H
    Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteral tube feeding of head and neck cancer patients undergoing definitive chemoradiotherapy in the Nordic Countries: Survey of the Scandinavian Society for Head and Neck Oncology.
    Ilmarinen T; Hammarstedt-Nordenvall L; Bäck L; Mäkitie A
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3489-3496. PubMed ID: 33389006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tube feeding during treatment for head and neck cancer - Adherence and patient reported barriers.
    Brown T; Banks M; Hughes BGM; Lin C; Kenny L; Bauer J
    Oral Oncol; 2017 Sep; 72():140-149. PubMed ID: 28797450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.